首页> 美国卫生研究院文献>BMC Cancer >Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)

【2h】

Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)

机译：改善淋巴瘤生存率联盟（CISL）对581例原发性肠非霍奇金淋巴瘤患者的多中心回顾性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundPrimary intestinal non-Hodgkin lymphoma (NHL) is a heterogeneous disease with regard to anatomic and histologic distribution. Thus, analyses focusing on primary intestinal NHL with large number of patients are warranted.

机译：背景原发性肠道非霍奇金淋巴瘤（NHL）就解剖学和组织学分布而言是一种异质性疾病。因此，必须针对大量患者进行针对原发性肠道NHL的分析。

著录项

期刊名称 BMC Cancer
作者
Seok Jin Kim; Chul Won Choi; Yeung-Chul Mun; Sung Yong Oh; Hye Jin Kang; Soon Il Lee; Jong Ho Won; Min Kyoung Kim; Jung Hye Kwon; Jin Seok Kim; Jae-Yong Kwak; Jung Mi Kwon; In Gyu Hwang; Hyo Jung Kim; Jae Hoon Lee; Sukjoong Oh; Keon Woo Park; Cheolwon Suh; Won Seog Kim;
展开▼
作者单位

展开▼
年(卷),期 2011(11),-1
年度 2011
页码 321
总页数 12
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
intestine non-Hodgkin lymphoma prognosis histopathology;

机译：肠;非霍奇金淋巴瘤;预后;组织病理学;

相似文献

外文文献
中文文献
专利

1. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) [J] . Seok Jin Kim, Chul Won Choi, Yeung-Chul Mun, BMC Cancer . 2011,第1期

机译：多中心回顾性研究从改善淋巴瘤生存率（CISL）联盟的581例原发性肠非霍奇金淋巴瘤患者
2. Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin’s lymphoma: a consortium for improving survival of lymphoma (CISL) trial [J] . Byeong-Bae Park, Won Seog Kim, Hyeon Seok Eom, Investigational New Drugs . 2011,第1期

机译：吉西他滨，异环磷酰胺，地塞米松和奥沙利铂（GIDOX）挽救疗法治疗B细胞非霍奇金淋巴瘤：改善淋巴瘤生存率的联合体（CISL）试验
3. Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial. [J] . Park BB, Kim WS, Eom HS, Investigational new drugs. . 2011,第1期

机译：吉西他滨，异环磷酰胺，地塞米松和奥沙利铂（GIDOX）挽救疗法治疗B细胞非霍奇金淋巴瘤：改善淋巴瘤生存率的联合体（CISL）试验。
4. INTESTINAL LYMPHOMA IN THE DOG: A MULTI-INSTITUTIONAL RETROSPECTIVE STUDY OF 60 CASES (1999-2008) TREATED WITH CHEMOTHERAPY [C] . Naoko Sogame, Rebecca E Ribson, Kim L Cronin, Annual conference of the Veterinary Cancer Society . 2008

机译：犬肠淋巴瘤：用化疗治疗60例（1999-2008）的多机构回顾性研究
5. Risk of Depressive or Anxiety Disorders in Commercially Insured Patients with Non-Hodgkin Lymphoma (NHL) in the US: A Retrospective Analysis [D] . Sun, Lucille 2017

机译：美国非霍奇金淋巴瘤（NHL）商业保险患者发生抑郁或焦虑症的风险：回顾性分析
6. Consortium for Improving Survival of Lymphoma (CISL): a model of multicenter collaboration for lymphoma studies in Korea [O] . Seok Jin Kim 2015

机译：改善淋巴瘤存活率的联合会（CISL）：韩国进行淋巴瘤研究的多中心合作模式
7. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) [O] . Seok Jin Kim, Chul Won Choi, Yeung-Chul Mun, 2011

机译：改善淋巴瘤生存率联盟（CISL）对581例原发性肠非霍奇金淋巴瘤患者的多中心回顾性分析

Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)

摘要

著录项

相似文献

相关主题

期刊订阅